Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
339,200,672
-
Number of holders
-
159
-
Total 13F shares, excl. options
-
197,748,566
-
Shares change
-
+11,382,191
-
Total reported value, excl. options
-
$526,027,143
-
Value change
-
+$38,581,662
-
Put/Call ratio
-
18592%
-
Number of buys
-
84
-
Number of sells
-
58
-
Price
-
$2.66
Institutional Holders of Nuvation Bio Inc. - Common Stock (NUVB) as of Q4 2024
183 filings reported holding NUVB - Nuvation Bio Inc. - Common Stock as of 31 Dec 2024.
Nuvation Bio Inc. - Common Stock (NUVB) had 159 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 197,748,566 shares of stock of the company.
Largest 10 holders included FMR LLC, Decheng Capital LLC, BlackRock, Inc., VANGUARD GROUP INC, Omega Fund Management, LLC, Octagon Capital Advisors LP, Laurion Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and MPM BIOIMPACT LLC.
This table shows the top 159 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.